Assistant Professor, Internal Medicine, Mayo Medical School

Hematology

Candido Rivera practices Hematology. He went to medical school at University of Puerto Rico School of Medicine. Candido E. Rivera is a published MD. He has 15 publications published. The most current publication "Infection of human endothelial cells with Epstein-Barr virus." Candido Rivera accepts Medicare.

Publications

---

• Use of the Functional Assessment of Cancer Therapy-Anemia in Persons with Myeloproliferative Neoplasm-Associated Myelofibrosis and Anemia.
• Clinical Reasoning: A 69-year-old man with Leukocytosis and hemorrhagic brain lesions.
• AT-101 downregulates BCL2 and MCL1 and potentiates the cytotoxic effects of lenalidomide and dexamethasone in preclinical models of multiple myeloma and Waldenstrom ma...
• The investigational agent MLN2238 induces apoptosis and is cytotoxic to CLL Cells in vitro, as a single agent and in combination with other drugs.
• Pomalidomide is active in the treatment of Anemia associated with myelofibrosis.
• The effect of sildenafil on human vascular function, platelet activation, and myocardial ischemia.
• Relationship between bone marrow failure Syndromes and the presence of glycophosphatidyl inositol-anchored protein-deficient clones.
• Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic Anemia syndrome.
• Identification of a new mutation in platelet glycoprotein IX (GPIX) in a patient with Bernard-Soulier Syndrome.
• Infection of human endothelial Cells with Epstein-Barr virus.
• Phase I/II study of melphalan, prednisone and lenalidomide combination for patients with newly diagnosed multiple myeloma who are not candidates for stem Cell transpla...
• The Myelofibrosis Symptom Assessment Form (MFSAF): an evidence-based brief inventory to measure quality of life and symptomatic response to treatment in myelofibrosis.
• Platelet count is a sensitive predictor of autologous peripheral blood progenitor cell collection yield in previously treated plasma cell Disease patients.
• In vitro and in vivo evidence of PNH cell sensitivity to Immune attack after nonmyeloablative allogeneic hematopoietic cell transplantation.

Schools

---

• University Of Puerto Rico School Of Medicine Medical Sciences Campus

• Jefferson University Hospital

• National Institutes Of Health Clinical Center

• University of Puerto Rico

Procedures Preformed

---

• Biopsy
• Bone Marrow Transplant
• HPC Transplantation (Stem Cell Transplant)
• Plasmapheresis
• View All

Conditions Treated

---

• Acute Leukemia
• Acute Lymphocytic Leukemia, Adult
• Amyloidosis
• Anemia
• View All

Doctors Specialties

---

• Hematology
• Medical Oncology
• Oncology

Accepted Insurances

---

Education

---

• National Institutes of Health Clinical Center
• Thomas Jefferson University
• University of Puerto Rico School of Medicine

Hospital

---

• Mayo Clinic - Jacksonville, Florida

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Pooja P. Advani, MD This Doctor is OpenDoctor Recommended.
	Dr. Mehdi M. Moezi, MD This Doctor is OpenDoctor Recommended.
	Dr. Keith M. Justice, MD This Doctor is OpenDoctor Recommended.
	Dr. Ruth R. Streeter, MD This Doctor is OpenDoctor Recommended.
	Dr. Alvaro Moreno-Aspitia, MD This Doctor is OpenDoctor Recommended.
	Dr. Jason S. Starr, DO
	Dr. Gerardo Colon-Otero, MD This Doctor is OpenDoctor Recommended.
	Dr. Joel Stone, MD This Doctor is OpenDoctor Recommended.
	Dr. Carlos M. Castillo, MD This Doctor is OpenDoctor Recommended.
	Dr. Leann L. Fox, MD This Doctor is OpenDoctor Recommended.
	Dr. Jeffrey M. Harris, MD
	Dr. Bhagirathbhai R. Dholaria, MD This Doctor is OpenDoctor Recommended.
	Dr. Ke Ning, MD This Doctor is OpenDoctor Recommended.
	Dr. Candido E. Rivera-Linares, MD This Doctor is OpenDoctor Recommended.
	Abhisek Swaika, MB BS
	Dr. David G. Hedrick, MD

---

Doctor Directory | TOS | twitter | FB | Angel | blog